Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Omnio raises €2.9 million to advance its plasminogen-based therapy for chronic wounds. This funding round was oversubscribed and led by existing investors.
Amount Raised
€2.9 Million
Round Type
Seed
UmeåBiotechnologyHealth CareMedicalTherapeuticsDescription
Omnio, a Umeå-based BioTech startup, has successfully raised €2.9 million from existing investors to advance its plasminogen-based therapy for hard-to-heal chronic wounds. The funds will help move the therapy closer to clinical studies. This follows a previous €4.3 million financing round to complete its GMP manufacturing process. The CEO expressed confidence in continued investor support for development.
Fundz sees it the moment Omnio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Omnio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.